Brief: Cancer Research Institute Launches Transformative Ai-Driven Immuno-Oncology Initiative Powered By 10X Genomics Technology
12/01/2026 14:06
Jan 12 (Reuters) - 10X Genomics Inc TXG.O: CANCER RESEARCH INSTITUTE LAUNCHES TRANSFORMATIVE AI-DRIVEN IMMUNO-ONCOLOGY INITIATIVE POWERED BY 10X GENOMICS TECHNOLOGY Source text: ID:nPnbBLdBJa Further company coverage: TXG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences